Cervarix more effective in girls aged 10-14

A new study indicates that GlaxoSmithKline's cervical cancer vaccine Cervarix appears to have a heightened response among girls aged 10 to 14. Researchers say this could mean that younger girls who are vaccinated may have a lower need for booster shots later in life. Cervarix has been shown to target two viruses that account for 70 percent of all cases of cervical cancer.

- read this report from the Independent for more